Patents by Inventor Adrienne DORRANCE

Adrienne DORRANCE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EPIDERMAL GROWTH FACTOR-LIKE 7 PEPTIDE AND USES THEREOF
    Publication number: 20230241170
    Abstract: The present disclosure relates to a recombinant endothelial growth factor like 7 (EGFL7) peptide and uses thereof for treating graft-versus-host disease (GVHD).
    Type: Application
    Filed: July 9, 2021
    Publication date: August 3, 2023
    Inventors: Adrienne DORRANCE, Martin GUIMOND
  • Antisense oligomers targeting HOXB-AS3 long non-coding RNA
    Patent number: 10787665
    Abstract: The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: September 29, 2020
    Assignees: Ohio State Innovation Foundation, Aalborg University
    Inventors: Ramiro Garzon, Adrienne Dorrance, Dimitrios Papaioannou, Robert Lee, Sakari Kauppinen, Andreas Petri, Charlotte AlbÆk Thrue
  • ANTISENSE OLIGOMERS TARGETING HOXB-AS3 LONG NON-CODING RNA
    Publication number: 20190256848
    Abstract: The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.
    Type: Application
    Filed: November 3, 2017
    Publication date: August 22, 2019
    Inventors: Ramiro GARZON, Adrienne DORRANCE, Dimitrios PAPAIOANNOU, Robert LEE, Sakari KAUPPINEN, Andreas PETRI, Charlotte ALBÆK THRUE